Han All Biopharma Co., Ltd.
Han All Biopharma Co., Ltd. is a Private limited company (Ltd.) registered in South Korea under 3068105479, and its current status with Supreme Court Internet Registry (IROS) is active. Its registered address on file is Daejeon, South Korea. 10 shareholders are on record for Han All Biopharma Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Supreme Court Internet Registry (IROS) and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
10
Shareholders of Han All Biopharma Co., Ltd.
10 shareholders are currently on record for Han All Biopharma Co., Ltd., filed with Supreme Court Internet Registry (IROS). The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 30.4% — the largest recorded stake — followed by iShares Core MSCI Emerging Markets ETF at 24.5%; the remaining 8 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 30.4% | Supreme Court Internet Registry (IROS) | |
| iShares Core MSCI Emerging Markets ETF | 24.5% | Supreme Court Internet Registry (IROS) | |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 17.9% | Supreme Court Internet Registry (IROS) | |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 8.5% | Supreme Court Internet Registry (IROS) | |
| Schwab Strategic Tr-Schwab International Small Cap Equity ETF | 4.5% | Supreme Court Internet Registry (IROS) | |
| DFA Emerging Markets Small Cap Series | 4.1% | Supreme Court Internet Registry (IROS) | |
| iShares Core MSCI Total International Stock ETF | 3.8% | Supreme Court Internet Registry (IROS) | |
| Vanguard International Stock Index-Pacific Stock Index | 2.8% | Supreme Court Internet Registry (IROS) | |
| College Retirement Equities Fund-Stock Account | 1.8% | Supreme Court Internet Registry (IROS) | |
| Vanguard Intl Equity Index – Total World Stock Index Fd | 1.7% | Supreme Court Internet Registry (IROS) |
Officers
7
Directors and officers of Han All Biopharma Co., Ltd.
The President, Co-ceo & Director of Han All Biopharma Co., Ltd. currently on record is Sean Jeong; seven officers are currently on record for Han All Biopharma Co., Ltd., filed with Supreme Court Internet Registry (IROS). Management authority at Han All Biopharma Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of Han All Biopharma Co., Ltd.
Han All Biopharma Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Hpi, Inc. (United States)
Data availability
Those 1 subsidiary spans South Korea, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Han All Biopharma Co., Ltd.
South Korea
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Han All Biopharma Co., Ltd.?
10 shareholders are currently on record for Han All Biopharma Co., Ltd., filed with Supreme Court Internet Registry (IROS). The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 30.4% — the largest recorded stake — followed by iShares Core MSCI Emerging Markets ETF at 24.5%; the remaining 8 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Han All Biopharma Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Han All Biopharma Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Han All Biopharma Co., Ltd. have on record?
10 shareholders are shown on record for Han All Biopharma Co., Ltd..
What is Han All Biopharma Co., Ltd.'s company registration number?
Han All Biopharma Co., Ltd.'s registration number is 3068105479, filed with Supreme Court Internet Registry (IROS) in South Korea. Its current status on the register is active.
Is Han All Biopharma Co., Ltd. still an active company?
Han All Biopharma Co., Ltd.'s status on Supreme Court Internet Registry (IROS) is listed as active.
What is Han All Biopharma Co., Ltd.'s registered address?
The registered address on file for Han All Biopharma Co., Ltd. is Daejeon, South Korea.
What legal structure is Han All Biopharma Co., Ltd. registered as?
Han All Biopharma Co., Ltd. is registered as a Private limited company (Ltd.) in South Korea.
Who are the officers/directors of Han All Biopharma Co., Ltd.?
The President, Co-ceo & Director of Han All Biopharma Co., Ltd. currently on record is Sean Jeong; seven officers are currently on record for Han All Biopharma Co., Ltd., filed with Supreme Court Internet Registry (IROS). Management authority at Han All Biopharma Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Han All Biopharma Co., Ltd. have a parent company or subsidiaries?
Han All Biopharma Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans South Korea, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Han All Biopharma Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from Supreme Court Internet Registry (IROS). Zavia's monitoring API can track changes to Han All Biopharma Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Han All Biopharma Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including South Korea, so records like Han All Biopharma Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Supreme Court Internet Registry (IROS) and was last synced on 25 September 2026.